Patrick Machado is an accomplished board member and chair, currently serving in various capacities across multiple companies, including Alumis, PROTA THERAPEUTICS PTY LTD, ACELYRIN, INC., and Xenon Pharmaceuticals Inc. Notable roles include Chair of the Board of Directors at PROTA THERAPEUTICS and Adverum Biotechnologies, as well as Chair of Audit Committees at both Alumis and ACELYRIN. Patrick has held significant positions across several organizations, utilizing extensive experience in governance and compensation committees since the late 2010s. Educational qualifications include a Juris Doctor from Harvard Law School and a dual degree in Economics and German from Santa Clara University.